Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 9, pp. 5903-5924
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

The JAK/STAT signaling pathway: from bench to clinic
Xiaoyi Hu, Jing Li, Maorong Fu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1408
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 443
Innate and adaptive immune responses against coronavirus
Arezoo Hosseini, Vida Hashemi, Navid Shomali, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110859-110859
Open Access | Times Cited: 149
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment
Di Wu, Yehao Luo, Tong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 100
Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
Martyna Strzelec, Jan Detka, Patrycja Mieszczak, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 75
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 18
Targeting STAT3 in cancer and autoimmune diseases
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, et al.
European Journal of Pharmacology (2020) Vol. 878, pp. 173107-173107
Closed Access | Times Cited: 87
An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years
Corrado Campochiaro, Yannick Allanore
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 57
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 38
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 12
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases
Brian S. Gerstenberger, Catherine M. Ambler, Eric P. Arnold, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13561-13577
Closed Access | Times Cited: 58
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.
Journal of Neuroimmunology (2021) Vol. 361, pp. 577758-577758
Open Access | Times Cited: 54
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
R. A. Moura, João Eurico Fonseca
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 50
Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
Cong Wang, Jinyi Lin, Yan Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 48
Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Shyam Lal Mudavath, et al.
Life Sciences (2022) Vol. 309, pp. 120996-120996
Closed Access | Times Cited: 36
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions
Allan R. Glanville, Christian Benden, Anne Bergeron, et al.
ERJ Open Research (2022) Vol. 8, Iss. 3, pp. 00185-2022
Open Access | Times Cited: 35
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted
Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Pharmacological Research (2022) Vol. 183, pp. 106359-106359
Closed Access | Times Cited: 28
Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease
Yerin Kim, Hyung-In Yang, Kyoung Soo Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14509-14509
Open Access | Times Cited: 16
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
Adriana Coricello, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2020) Vol. 25, Iss. 15, pp. 3321-3321
Open Access | Times Cited: 44
Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development
Tomasz M. Grzywa, Magdalena Justyniarska, Dominika Nowis, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 870-870
Open Access | Times Cited: 35
EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype
Narjara González Suárez, Sahily Rodriguez Torres, Amira Ouanouki, et al.
Molecules (2021) Vol. 26, Iss. 6, pp. 1506-1506
Open Access | Times Cited: 32
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
Rasmus Westermann, René Cordtz, Kirsten Duch, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 93-102
Closed Access | Times Cited: 14
Revealing innovative JAK1 and JAK3 inhibitors: a comprehensive study utilizing QSAR, 3D-Pharmacophore screening, molecular docking, molecular dynamics, and MM/GBSA analyses
Abdelmoujoud Faris, Ivana Cacciatore, Radwan Alnajjar, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top